Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS

被引：0

作者：

Li, Peng ^{[1
,2
]}

Alnoor, F. N. U. ^{[1
,3
]}

Xie, Wei ^{[4
]}

Williams, Margaret ^{[1
,2
]}

Feusier, Julie ^{[1
,2
]}

Ding, Yi ^{[5
]}

Zhao, Xiangrong ^{[6
]}

Zheng, Gang ^{[7
]}

Zhao, Chen ^{[8
]}

Zieske, Arthur W. ^{[9
]}

Zu, Youli ^{[9
]}

Raess, Philipp W. ^{[4
]}

Tantravahi, Srinivas ^{[10
,11
]}

Osman, Afaf ^{[10
,11
]}

Patel, Ami B. ^{[10
,11
]}

Tashi, Tsewang ^{[10
,11
]}

Patel, Jay L. ^{[1
,2
]}

Matynia, Anna P. ^{[1
,2
]}

Menon, Madhu P. ^{[1
,2
]}

Miles, Rodney R. ^{[1
,2
,11
]}

Jacobsen, Jeffrey R. ^{[1
,2
]}

George, Tracy I. ^{[1
,2
,11
]}

Sborov, Douglas W. ^{[10
,11
]}

Szankasi, Philippe ^{[2
]}

Rindler, Paul ^{[2
]}

Close, Devin ^{[2
]}

Ohgami, Robert S. ^{[1
,2
]}

机构：

[1] Univ Utah Hlth, Dept Pathol, Salt Lake City, UT 84132 USA

[2] ARUP Labs, Salt Lake City, UT 84108 USA

[3] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA

[4] Oregon Hlth & Sci Univ, Sch Med, Dept Pathol & Lab Med, Portland, OR USA

[5] Geisinger Med Ctr, Lab Med, Danville, PA USA

[6] Kaiser Permanente, Sacramento, CA USA

[7] Mayo Clin Labs, Rochester, MN USA

[8] Case Western Reserve Univ, Dept Pathol & Lab Med, Cleveland, OH USA

[9] Houston Methodist Hosp, Pathol & Genom Med, Houston, TX USA

[10] Univ Utah Hlth, Dept Internal Med, Salt Lake City, UT USA

[11] Huntsman Canc Inst, Salt Lake City, UT USA

来源：

LEUKEMIA | 2025年 / 39卷 / 01期

关键词：

D O I：

10.1038/s41375-024-02397-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：248 / 256

页数：9

共 50 条

[31] LYMPHOPENIA IS AN INDEPENDENT RISK-FACTOR IN PATIENTS WITH LOW-RISK MDS ACCORDING TO THE IPSS-R
Silzle, T.
Schuler, E.
Hildebrandt, B.
Blum, S.
Haas, R.
Germing, U.
HAEMATOLOGICA, 2017, 102 : 263 - 263
[32] A prediction rule to identify low-risk patients with community-acquired pneumonia
Fine, MJ
Auble, TE
Yealy, DM
Hanusa, BH
Weissfeld, LA
Singer, DE
Coley, CM
Marrie, TJ
Kapoor, WN
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (04): : 243 - 250
[33] Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
M Y Follo
S Mongiorgi
C Clissa
S Paolini
G Martinelli
A M Martelli
G Fioravanti
L Manzoli
C Finelli
L Cocco
Leukemia, 2012, 26 : 2474 - 2482
[34] MESENCHYMAL STROMAL CELLS MAY ENHANCE RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS
Jimenez Solas, T.
Muntion Olave, S.
Lopez, F.
Ortega Herrera, R.
Martin Izquierdo, M.
Gonzalez Martinez, T.
Janusz, K.
Ezponda, T.
Vilas, A.
Alfonso, A.
Prosper, F.
Molero, A.
Valcarcel, D.
Sanchez-Guijo, F.
Diez-Campelo, M.
LEUKEMIA RESEARCH, 2021, 108 : S39 - S39
[35] Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
Follo, M. Y.
Mongiorgi, S.
Clissa, C.
Paolini, S.
Martinelli, G.
Martelli, A. M.
Fioravanti, G.
Manzoli, L.
Finelli, C.
Cocco, L.
LEUKEMIA, 2012, 26 (12) : 2474 - 2482
[36] Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment
Follo, Matilde Y.
Mongiorgi, Sara
Clissa, Cristina
Fili, Carla
Colombi, Chiara
Baccarani, Michele
Martinelli, Giovanni
Russo, Domenico
Manzoli, Lucia
Martelli, Alberto M.
Finelli, Carlo
Cocco, Lucio
BLOOD, 2010, 116 (21) : 108 - 108
[37] New risk group staging according to new R-IPSS of 25 patients with low-risk MDS
Tatic, A.
Jardan, C.
Georgescu, O.
Stanca, O.
Vasilica, M.
Badelita, S.
Crisan, A. M.
Colita, A.
Colita, D.
Vulcan, G.
Lupu, A. R.
Coriu, D.
LEUKEMIA RESEARCH, 2013, 37 : S98 - S99
[38] Usefulness of a predictive model to hospitalize patients with low-risk community-acquired pneumonia
Adriana Lama
Francisco Gude
María Elena Toubes
Ana Casal
Jorge Ricoy
Carlos Rábade
Nuria Rodríguez-Núñez
Ana Cao-Ríos
Uxío Calvo
Luis Valdés
European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 61 - 71
[39] Applying a prediction rule to identify low-risk patients with community-acquired pneumonia
Marras, TK
Gutierrez, C
Chan, CK
CHEST, 2000, 118 (05) : 1339 - 1343
[40] FREQUENCY AND CLINICAL RELEVANCE OF PNH CLONES IN A POPULATION OF LOW-RISK AND INTERMEDIATE-1 RISK MDS PATIENTS: A GROM-L STUDY
Buccisano, F.
Conti, C.
Niscola, P.
Cimino, G.
Fianchi, L.
Bellesi, S.
Campagna, A.
Amodeo, R.
Sarlo, C.
Gumenyuk, S.
Fenu, S.
Piccioni, A.
Latagliata, R.
Mancini, S.
Armentano-Conte, C.
Sala, R.
Consalvo, M. Irno
Attrotto, C.
Fraboni, D.
Maurillo, L.
HAEMATOLOGICA, 2017, 102 : 6 - 6

← 1 2 3 4 5 →